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Abstract
Background: Telemedicine is often suggested as a promising approach to support patients with diabetes. However, the
effectiveness of diabetes-related telemedicine interventions in regard to patient-related outcomes requires further evaluation.
Previous systematic reviews describing the effectiveness of telemedicine in diabetes management focus on a specific type of
telemedicine, a specific type of diabetes, specific comparators, or specific outcomes. Moreover, the rapid development within
telemedicine emphasizes the need for a new review.
Objective: The present review has a broad scope with an eye to performing an updated and exhaustive review within the field.
The review aims to evaluate the effectiveness of existing telemedicine solutions versus any comparator without the use of
telemedicine on diabetes-related outcomes among adult patients with diabetes.
Methods: The review will consider studies that include adult subjects with a diagnosis of diabetes (type 1, 2, or gestational),
studies that evaluate various types of telemedicine interventions, and randomized controlled trials comparing a telemedicine
intervention to any control that does not include telemedicine. Peer-reviewed full-text papers in English, Norwegian, Danish, and
Swedish will be considered. A thorough search will be performed in the PubMed, CINAHL, EMBASE, and Cochrane Library
Central Register of Controlled Trials (CENTRAL) databases. Data extraction will include details about the populations, study
methods, interventions, and outcomes of significance based on the review objective.
Results: The results of the review are expected to provide an estimate of the treatment effect. The studies will be pooled via
statistical meta-analysis and supplemented with narrative comparisons when necessary.
Conclusions: The review is important as it will inform clinicians and investigators about the effect of various telemedicine
solutions within the field of diabetes.
International Registered Report Identifier (IRRID): DERR1-10.2196/22062
(JMIR Res Protoc 2020;9(11):e22062) doi: 10.2196/22062
KEYWORDS
diabetes mellitus; glycemic control; HbA1c; telehealth
JMIR Res Protoc 2020 | vol. 9 | iss. 11 | e22062 | p. 1http://www.researchprotocols.org/2020/11/e22062/
(page number not for citation purposes)
Laursen et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
Introduction
Diabetes poses a major health care problem worldwide. In 2017,
an estimated 8.4% of the adult world population had diabetes,
and this number is predicted to increase to approximately 9.9%
(425 million) in 2045 due to an increase in unhealthy dietary
habits, overweight, physical inactivity, and other risk factors
[1,2]. Type 1 diabetes (T1D) and type 2 diabetes (T2D) represent
approximately 5%-8% and 90%-95% of diabetes cases,
respectively, and preexisting T1D, T2D, or gestational diabetes
mellitus (GDM) occur in approximately 1 of 6 pregnancies
[1,3-5].
T1D and T2D are associated with premature death and several
complications such as cardiovascular disease, nephropathy,
neuropathy, and retinopathy [6]. Preexisting diabetes during
pregnancy and GDM is associated with both maternal and
neonatal complications such as preeclampsia, miscarriages,
stillbirth, birth complications, and congenital abnormalities
[5,7]. Furthermore, women with GDM and their babies have a
considerably higher risk of developing T2D later in life [7].
Optimal glycemic control is crucial for the prevention and
control of diabetes-related complications [5,6]. However,
sustaining optimal glycemic control in the context of diabetes
is challenging given that diabetes is a demanding chronic disease
that requires numerous daily self-management decisions and
the performance of complex care activities. One example is the
challenge in estimating the appropriate diabetes medication
dosage to avoid hypo- and hyperglycemic events, which requires
consideration of various influencing factors. Another example
is adherence obstacles with regard to following the
recommended guidelines [6,8].
Self-management support in the management of diabetes is a
recognized approach to help people with diabetes navigate
unavoidable decisions and activities related to the disease, and
is known to be associated with improvements in health-related
outcomes [8]. The American Association of Diabetes refers to
diabetes self-management support as activities that provide
educational, behavioral, psychological, or clinical assistance in
“implementing and sustaining the behaviors needed to manage
his or her condition on an ongoing basis” [9]. Hence,
self-management support should be highly prioritized in the
management of diabetes.
Telemedicine has been suggested as a promising but unproven
approach to support people with diabetes in the control of their
disease [10]. Telemedicine includes the use of
telecommunication and information technology to deliver health
care services, including monitoring, education, consultative
services, and counseling tasks, at a distance. Telemedicine
interventions embrace various constellations such as simple
reminders via text messaging, video consultation, and
transmission of patient data (eg, blood glucose, blood pressure,
dietary and medication intake) with feedback from health care
professionals via web portal interfaces or the telephone. As
diabetes mainly needs to be managed outside health care
facilities, telemedicine could be an obvious solution to provide
self-management support to people with diabetes. Moreover,
telemedicine could be relevant to those who have difficulties
traveling to health care facilities due to disabilities or large
distances [11,12]. A recent systematic review and meta-analysis
concluded that the use of telehealth solutions among people
with diabetes is a safe option for the delivery of
self-management support [13]. However, the approach still
needs to be sufficiently evaluated in regard to its effectiveness
in terms of patient-related outcomes (eg, clinical, behavioral,
and psychological) within the diabetes context. Given this
situation, a comparison and review of the effectiveness of
different types of telemedicine interventions is highly relevant.
Previous systematic reviews describing the effectiveness of
telemedicine for the management of diabetes exist [10,14-24].
However, these reviews are limited to specific types of
telemedicine (eg, telemonitoring) [14,17-22], a specific diabetes
type [15,23,24], specific outcomes (eg, hemoglobin A1c)
[10,16], or specific comparators (typically usual care) [10,22].
In T2D, a previous systematic review observed heterogeneity
among the included telemedicine studies, which may partly be
explained by the variations in the types of telemedicine used
[8]. This observation underlines the need for a review including
a specific analysis considering the different types of
telemedicine. The call for a new systematic review and
meta-analysis of telemedicine solutions among people living
with diabetes is further indicated due to the rapid development
in the field of telemedicine. Hence, the expectation is that a
large number of additional studies have been published since
the performance of the previous reviews. Moreover, the
possibility of integrating more telemedicine solutions increases
in relevance owing to the increasing focus on the efficiency of
health care resources [25].
The above-mentioned considerations suggest the value of a new
and extensive review in the field. Therefore, the objective of
this systematic review and meta-analysis will be to evaluate the
effectiveness of existing telemedicine solutions versus any
comparator without the use of telemedicine on diabetes-related
outcomes among adult patients with diabetes. Telemedicine is
defined as telecommunication and information technology that
delivers health care services at a distance [11,12].
Methods
Study Design
The review will be conducted and reported according to the
PRISMA (Preferred Reporting Items for Systematic Reviews
and Meta-analyses) guidelines [26], and a search protocol
registered April 21, 2020 on PROSPERO (CRD42020123565)
will form the basis of the review process.
Review Question
The question of this systematic review and meta-analysis is as
follows: How effective are telemedicine solutions versus any
comparator without the use of telemedicine in regard to
diabetes-related outcomes among adult patients with diabetes?
As the question indicates, the review has a very broad scope.
Hence, the review considers (1) studies related to T1D, T2D,
and GDM; (2) all patient-related outcomes
(physiological/clinical, psychological, and behavioral); and (3)
any comparator that does not include telemedicine.
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Inclusion Criteria
Participants
This systematic review and meta-analysis will consider studies
that included adults ≥18 years of age who were diagnosed with
T1D, T2D, or GDM. Studies that focused on pregnant women
with preexisting T1D or T2D will also be considered. Studies
reporting mixed disease populations (eg, diabetes and heart
disease), mixed diabetes types, or mixed age groups (children
and adults) will be included if the data for the population with
diabetes or adult age group are reported separately in a
transparent subgroup analysis. Studies will be excluded if they
only include subjects at risk of diabetes or individuals with
prediabetes.
Interventions
This systematic review and meta-analysis will consider studies
that evaluate telemedicine interventions as a substitute or
alternative to usual practice (ie, interventions with remote
feedback/communication between either the patient and health
care professional[s] or between the patient and trained peer[s]).
Furthermore, wholly automatic telemedicine interventions will
be considered. The telemedicine interventions may include
various technologies such as telephone, smartphone, mobile
phone, fax, text messaging, tablet, personal digital assistant,
computer, and monitoring equipment (eg, glucometer, weight
scale, pedometer, or sphygmomanometer) [11,12].
Comparators
This systematic review and meta-analysis will consider studies
that compare the intervention to usual care or an alternative
intervention without telemedicine. Both parallel and crossover
designs will be considered.
Outcomes
This systematic review and meta-analysis will consider studies
that report on any patient diabetes-related outcome(s) (ie, any
physiological, psychological, or behavioral outcome). The
primary outcome for T1D and T2D will be glycemic control,
measured as a change in glycated hemoglobin (%). The primary
outcome for pregnancy-related diabetes will be birth weight.
Study Types
This systematic review and meta-analysis will only consider
randomized clinical trials (RCTs) with both a parallel and
crossover design. Furthermore, studies will be included if the
researchers consider the study to have adopted an RCT design
based on the methodological approach of the individual study
even if is the paper states that it used another design (eg, a
quasiexperimental study design). Studies published in English,
Danish, Norwegian, and Swedish as peer-reviewed full-text
papers will be included. All studies published before the
submission of the paper will be included, as both older and
newer interventions are considered to bring value to the study
(an updated search will be performed prior to submission).
Search Strategy
The search strategy aims to locate both published and
unpublished studies. An initial limited search of the PubMed
and CINAHL databases will be undertaken to identify articles
on the topic. The text words contained in the titles and abstracts
of relevant articles and the index terms used to describe the
articles will be used to perform a full search using PubMed,
EMBASE, CINAHL, and the Cochrane Library Central Register
of Controlled Trials (CENTRAL) databases. The full search
history in PubMed is provided in Multimedia Appendix 1. The
search strategy, including all identified keywords and index
terms, will be adapted for each included information source.
Search terms will include different synonyms, near-synonyms,
spellings, and acronyms for each identified keyword and index
term. Moreover, different search functions such as thesaurus,
Boolean operators, truncation, abstract/title/keywords, phrase,
free text, and advanced search will be applied to focus and
structure the search.
To prevent selection bias, a follow-up search will be performed
in each of the four databases prior to manuscript submission.
Citation searches and manual searches of the reference lists of
relevant systematic reviews and of all studies selected for critical
appraisal will be performed to identify additional studies.
Information Sources
The databases to be searched are PubMed (no limitation of
search years), EMBASE (no limitation of search years),
CENTRAL (no limitation of search years), and CINAHL (no
limitation of search years). Two review authors will perform
the database searches in collaboration with a research librarian.
Citation searches will be performed in SCOPUS, Web of
Science, and through Google Scholar. ClinicalTrials will be
searched to identify unpublished studies.
Authors of identified articles will be contacted if an article is
not possible to access or if any question occurs during the
selection or extraction processes.
Study Selection
Following the search, all identified citations will be collated
and uploaded into RefWorks (Refworks, RefWorks-COS,
ProQuest RefWorks 2.0, 2010), where the functions Exact
duplicates and Close duplicates will be used for duplicate
removal. Titles and abstracts will then be screened by two
independent reviewers for assessment against the inclusion
criteria of the review. Potentially relevant studies will be
retrieved in full and assessed in detail by two independent
reviewers against the inclusion criteria. Records on which the
reviewers agree will be included in the systematic review. Any
disagreement that arises between the reviewers at each stage of
the study selection process will be resolved through discussion
between the two reviewers or by including other reviewers in
the decision-making process.
Reasons for exclusion of full-text studies that do not meet the
inclusion criteria will be recorded and reported in the systematic
review and meta-analysis. The results of the search will be
reported in full in the final systematic review and meta-analysis,
and presented in a PRISMA flow chart as shown in Multimedia
Appendix 2 [26].
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Assessment of Methodological Quality
The risk of bias assessment of eligible studies will be performed
by two or more independent reviewers using the revised
Cochrane risk-of-bias tool [27].
Authors of papers will be contacted to request missing or
additional data for clarification when required. Any
disagreements that arise between the reviewers will be resolved
through discussion or with a third or additional reviewer(s). The
results of the risk-of-bias assessment of the eligible studies will
be reported in a risk-of-bias chart using the revised Cochrane
risk-of-bias tool [27].
All studies, regardless of the results of their methodological
quality, will undergo data extraction and synthesis (where
possible).
Data Extraction
Data will be extracted from the studies included in the review
by three independent reviewers using tables in Microsoft Excel
2016. The data extracted will include specific details about the
populations, study methods, interventions, and outcomes of
significance based on the review objective. More specifically,
three categories are considered relevant: (1) baseline
characteristics of the study populations, (2) trial characteristics
and key results, and (3) characteristics of the telemedicine
interventions.
Any disagreements that arise between the reviewers will be
resolved through discussion or with a third or additional
reviewer(s).
Data Synthesis
All included studies will be pooled via a statistical meta-analysis
to provide an overall estimate of the treatment effect.
Meta-analyses will be performed with the RevMan VX.X
(Copenhagen: The Nordic Cochrane Centre, Cochrane) software
tool for T1D and GDM, and with Stata 14 software (StataCorp
2015. Stata Statistical Software: Release 14. College Station,
TX: StataCorp LP) for T2D. Effect sizes will be expressed as
relative risks for dichotomous data. For continuous outcomes,
effect sizes will be expressed as the mean (SD) change in
outcomes from baseline to follow up for both groups, and, if
not available, the absolute mean (SD) at follow up for both
groups will be used. From this, the mean difference between
the intervention and control group (or standardized mean
difference) and confidence intervals can be calculated for each
study. Heterogeneity will be assessed qualitatively by comparing
the characteristics of the studies and statistically using I2 tests.
Statistical analyses will be performed using a fixed-effects
model except if heterogeneity is deemed as being present
(I2>50%), in which case a random-effects model will be used.
Subgroup analyses on types of telemedicine will be conducted
when appropriate. Where statistical pooling is not possible, the
findings will be presented in narrative form, including tables
and figures to aid in data presentation when appropriate. A
funnel plot will be generated to assess publication bias if there
are 10 or more studies included in a meta-analysis. Statistical
tests for funnel plot asymmetry (Egger test, Begg test, Harbord
test) will be performed when appropriate.
Data Reporting
Three systematic reviews and meta-analyses will be conducted
to obtain the results: one report on studies related to diabetes
during pregnancy, one report on T1D studies (not related to
pregnancy), and one report on T2D studies (not related to
pregnancy). This subdivision is considered relevant to ensure
a clear and easily accessible report of the results. The flowchart
of the search will be reported in each of the reviews as it appears
in Multimedia Appendix 2.
Assessing Certainty in the Findings
The Grading of Recommendations, Assessment, Development
and Evaluation (GRADE) approach for grading the certainty of
evidence will be used, and a Summary of Findings (SoF) will
be created using GRADEPro GDT 2015 (McMaster University,
ON, Canada; developed by Evidence Prime, Inc) [28]. The SoF
will present the following information where appropriate:
absolute risks for the treatment and control groups; estimates
of relative risk; and a ranking of the quality of the evidence
based on the risk of bias, directness, heterogeneity, precision,
and risk of publication bias of the review results. The outcomes
reported in the SoF will be hemoglobin A1c (%) for T1D and
T2D and birth weight for pregnancy-related diabetes.
Results
The systematic review is ongoing. A preliminary search in
PubMed resulted in retrieval of 4813 records (Multimedia
Appendix 1). The results of the review are expected to provide
an estimate of the treatment effect. The studies will be pooled
via statistical meta-analysis and supplemented with narrative
comparisons when necessary. The results will be submitted for
publication and peer review.
Discussion
The review is expected to have strengths as well as limitations.
On the one hand, the search of literature will be very inclusive
and exhaustive, which is a strength. On the other hand, the
review is expected to be limited by the lack of homogeneity
between the included telemedicine studies, as telemedicine
studies tend to differ in intervention type, inclusion criteria,
technology, and other aspects. The comparison of studies is
expected to be complicated due to this divergence.
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